Zhenming Shun

Janus kinase-2 inhibitor fedratinib in patients with myelofibrosis previously treated with ruxolitinib (JAKARTA-2): a single-arm, open-label, non-randomised, phase 2, multicentre study

Claire Harrison, Nicolaas Schaap, Alessandro M. Vannucchi et al. · The Lancet Haematology · 2017 · 330 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +5

Laplace Approximation of High Dimensional Integrals

Zhenming Shun, Peter McCullagh · Journal of the Royal Statistical Society Series B (Statistical Methodology) · 1995 · 225 citations

Natural Sciences, High-performance Computing, Computational Physics +9

A Multicenter, Phase 2 Study of Vascular Endothelial Growth Factor Trap (Aflibercept) in Platinum- and Erlotinib-Resistant Adenocarcinoma of the Lung

Natasha B. Leighl, Luis E. Raez, Benjamin Besse et al. · Journal of Thoracic Oncology · 2010 · 89 citations · Full text

Medicine, Oncology, Pharmacology +16

Type I error in sample size re‐estimations based on observed treatment difference

Zhenming Shun, William Yuan, William E. Brady et al. · Statistics in Medicine · 2001 · 61 citations

Natural Sciences, Biostatistics, Mathematics +17

Another Look at the Salamander Mating Data: A Modified Laplace Approximation Approach

Zhenming Shun · Journal of the American Statistical Association · 1997 · 61 citations

Life Sciences, Biostatistics, Zoology +16